[Epidemiology of hepatitis C in Japan].
Yano
Koji
K
Division of International Collaboration, Clinical Research Center, WHO Collaboration Centre for Reference and Research on Viral Hepatitis, National Nagasaki Medical Center.
Yatsuhashi
Hiroshi
H
Yano
Michitami
M
D000367:Age Factors; D000998:Antiviral Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D014943:Global Health; D006526:Hepatitis C / Q000188:drug therapy / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D007372:Interferons / Q000627:therapeutic use; D007564:Japan / Q000453:epidemiology; D015995:Prevalence; D012254:Ribavirin / Q000627:therapeutic use; D016036:Seroepidemiologic Studies; D013997:Time Factors
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons